期刊文献+

V_(1a)/V_2受体在精氨酸血管加压素恢复失血诱导大鼠血管低反应性中的作用 被引量:3

Effect of V_(1a) and V_2 receptor on the increase of vascular reactivity after hemorrhagic shock induced by arginine vasopressin
下载PDF
导出
摘要 目的探讨精氨酸血管加压素(AVP)在恢复失血性休克动物血管反应性和钙敏感性中的可能机制和血管加压素V1 a、V2受体对其的作用。方法实验分2部分:在体实验,观察AVP(0.04、0.1、0.4 U/kg)对失血性休克大鼠肠系膜动脉(SMA)血管管径对去甲肾上腺素(NE)收缩反应性的影响;离体实验,取失血性休克大鼠SMA环,利用离体血管环张力测定技术,观察V1 a和V2受体拮抗剂对AVP恢复失血性休克大鼠肠系膜动脉反应性和钙敏感性的影响。结果失血性休克后,大鼠肠系膜动脉对NE的收缩反应性明显降低,AVP各剂量均明显升高了休克大鼠SMA对NE的收缩反应。离体实验,AVP(5×10-10mol/L)可明显恢复休克后的血管低反应性和钙失敏;而AVP V1 a受体拮抗剂预处理可明显抑制AVP诱导的SMA对NE和Ca2+的反应性升高(P<0.01),V2受体拮抗剂也部分抑制了AVP的作用。结论AVP恢复失血性休克动物血管反应性和钙敏感性的机制与其V1 a和V2受体有关,其中V1 a受体可能发挥着更为重要的作用。 Objective To observe the effect of AVP on vascular reactivity and calcium sensitivity following hemorrhagic shock and its relations to V1a and V2 receptor in rats. Methods In vivo,the effects of AVP (0.04, 0.1 and 0.4U/kg) on the vasoconstriction of superior mesenteric artery (SMA) to norepinephrine (NE) were observed in hemorrhagic shock (30 mmHg for 2 hours) rats. In vitro, the effects of V1a and V2 receptor inhibitor on the increase of vascular reactivity and calcium sensitivity of SMA from hemorrhagic shock rats induced by arginine vasopressin were observed. Results In vivo, AVP ( 0.04,0.1 and 0.4U/kg ) significantly increased the vasoconstriction of SMA to NE in hemorrhagic shock rats,and in vitro,AVP (5 × 10^-10mol/L) pretreatment also improved reactivity of SMA to NE and calcium following hemorrhagic shock. The V1a receptor inhibitor significantly antagonized AVP-induced increase of vascular reactivity and calcium sensitivity of SMA following hemorrhagic shock and V2 receptor inhibitor also partly inhibited this effect. Conclusion AVP may restore the decreased vascular reactivity and calcium sensitivity of vascular smooth muscle after hemorrhagic shock through V1a and V2 receptor,and V1a receptor may play more important role than V2 receptor.
出处 《创伤外科杂志》 2008年第1期57-60,共4页 Journal of Traumatic Surgery
基金 国家自然科学基金项目(30625037) 国家重点基础发展计划资助项目(2005CB522601)
关键词 失血性休克 精氨酸 血管加压素 受体 血管反应性 hemorrhagic shock arginine vasopressin receptor vascular reactivity
  • 相关文献

参考文献9

  • 1Dunser MW,Mayr AJ,Ulmer H,et al.Arginine vasopressin in advanced vasodilatory shock:a prospective,randomized,controlled study[J].Circulation,2003,107(18):2313-2319.
  • 2Yang GM,Liu LM,Xu J,et al.Effect of arginine vasopressin on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rho-kinase[J].J Trauma,2006,61(6):1336-1342.
  • 3杨光明,刘良明.新型钙增敏剂MCI-154对失血性休克大鼠血管反应性的影响[J].创伤外科杂志,2005,7(2):118-122. 被引量:4
  • 4Sharshar T,Carlier R,Blanchard A,et al.Depletion of neurohypophyseal content of vasopressin in septic shock[J].Crit Care Med,2002,30(3):497-500.
  • 5Holmes CL,Landry DW,Granton JT.Science review:vasopressin and the cardiovascular system part 1-receptor physiology[J].Crit Care,2003,7(6):427-434.
  • 6Force T,Kyriakis JM,Avruch J,et al.Endothelin,vasopressin,and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and-independent pathways in glomerular mesangial cells[J].J Biol Chem,1991,266(10):6650-6656.
  • 7Ishunina TA,Swaab DF.Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus:size changes in relation to age and sex[J].J Clin Endocrinol Metab,1999,84(12):4637-4644.
  • 8Li YX,Shiels AJ,Maszak G,et al.Vasopressin-stimulated Ca2+ spiking in vascular smooth muscle cells involves phospholipase D[J].Am J Physiol Heart Circ Physiol,2001,280(6):H2658-2664.
  • 9Araki S,Ito M,Kureishi Y,et al.Arachidonic acid-induced CaI2+ sensitization of smooth muscle contraction through activation of Rho-kinase[J].Pflugers Arch,2001;441(5):596-603.

二级参考文献9

  • 1Mei JM,Hu DY,Chen HS,et al.Effect of MCI-154,a calcium sensitizer on calcium sensitivity of myocardial fibers in endotoxic shock rats[J].Shock,2000,14(6):652-656.
  • 2Mei JM,Hu DY,Chen HS,et al.Effects of MCI-154,a calcium sensitizer,on cardiac dysfunction in endotoxic shock in rabbits[J].Shock,2000,13(6):459-463.
  • 3Okafor C,Liao R,Perreault MC,et al.Mg-ATPase and Ca+ activated myosin ATPase activity in ventricular myofibrils from non-failing and diseased human hearts-effects of calcium sensitizing agents MCI-154,DPI 201-106, and caffeine[J].Mol Cell Biochem,2003,245(1-2):77-89.
  • 4Korvald C,Nordhaug DO,Steensrud T,et al.Vasodilation and mechan-oenergetic inefficiency dominates the effect of the "Ca2+-sensitizer" MCI-154 in intact pigs[J].Scand Cardiovasc J,2002,36(3):172-179.
  • 5Hikaru H,Guifa C,Hideharu O,et al.Electrophysiological comparison of the effects of MCI-154 on smooth muscles between mesenteric artery and vein of dogs[J].General Pharmacology:the Vascular System,1993,24(2):333-339.
  • 6Andrea JE,Walsh MP.Protein kinase C of smooth muscle[J].Hypertension,1992,20:585-589.
  • 7梅建民,胡德耀,陈惠孙,刘良明,廖世海,吴炎.钙增敏剂MCI-154对内毒素休克家兔治疗作用的实验研究[J].第三军医大学学报,1998,20(6):492-495. 被引量:5
  • 8殷作明,胡德耀,刘良明,李素芝,雷明全,任冬梅.新型钙增敏剂MCI-154对失血性休克大鼠的治疗作用[J].西藏科技,1999(2):76-80. 被引量:3
  • 9殷作明,胡德耀,刘良明,卢儒权,陈艳,黄钢.新型钙增敏剂MCI-154对失血性休克动物心肌的保护作用[J].中华创伤杂志,2000,16(3):163-165. 被引量:4

共引文献3

同被引文献37

  • 1邱海波,郭风梅,郑瑞强.《2004严重感染和感染性休克治疗指南》系列讲座(3) 严重感染和感染性休克的抗感染治疗[J].中国危重病急救医学,2004,16(9):515-517. 被引量:10
  • 2郑永科,刘长文,朱克毅,陆俊,胡炜.特利加压素在脓毒血症难治性休克中的应用价值[J].浙江临床医学,2007,9(4):455-456. 被引量:7
  • 3贾建平.神经病学[M].北京:人民卫生出版社,2008,420
  • 4李忠仁.实验针灸学[M].北京:中周中医药出版社,2008:255-256.
  • 5Howl J,IsmaiiT,Strain AJ,et al. Characterization of the human liver vasopressin receptor [ J ]. Biochem J ’ 1991 (276) :189.
  • 6Vakili, Abedin,Kataoka,et al. Role of argininevasopressin VI and V2 receptors for brain damage after transient focal cerebral ischemia[ J]. Cereb Blood Flow Metab,2005(25) :1012 -1019.
  • 7Lebrun CJ,Grober WG,Meister M,et al. Central vasopressin pretreatment sensitizes phosphoinositol hydrolysisi in the rat septum[ J]. Btain Res,1990(31) :167.
  • 8Griebel G,Simiand J, Serraoleil - Le, et al. Anxiolytic - and antidepressant - like effects of the non - peptide vasopressin VI b receptor antagonist, SSR149415, suggest an innovative approach for the treat-ment of stress - related disorders[ J]. Proc. Natl Acad. Sci. USA,2002(99):6370 -6375.
  • 9Griebel G,Simiand J,Stemmelin J,et al. The vasopressin VIb receptor as a therapeutic target in stress - related disorders [ J ]. Current Drug Target CNS Neurol Disorder ,2003 ( 2 ) ; 191 -200.
  • 10Mar Cuadrado-Tejedor,Ana L. Ricobaraza,Rosana Torrijo,Rafael Franco,Ana Garcia-Osta.Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer?s Disease-like Phenotype of a Commonly Used Mouse Model[J]. Current Pharmaceutical Design . 2013 (28)

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部